α-Synuclein mutations cluster around a putative protein loop☆

Highlights • We map all five missense SNCA mutations on the proposed α-synuclein protein models.• 4 mutations cluster around the protein loop linking the two legs of the hairpin.• 4 mutations cluster around the point of hairpin convergence for tetramer formation.

[1]  M. Farrer,et al.  Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication , 2007, Neurology.

[2]  Philipp Selenko,et al.  Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature? , 2012, Biochemical Society transactions.

[3]  C. Griesinger,et al.  Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation. , 2008, Journal of the American Chemical Society.

[4]  D. Selkoe,et al.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation , 2011, Nature.

[5]  Christian Griesinger,et al.  Structural basis behind the interaction of Zn²⁺ with the protein α-synuclein and the Aβ peptide: a comparative analysis. , 2012, Journal of inorganic biochemistry.

[6]  Christos Proukakis,et al.  A novel α-synuclein missense mutation in Parkinson disease , 2013, Neurology.

[7]  F. Marken,et al.  The synucleins are a family of redox-active copper binding proteins. , 2011, Biochemistry.

[8]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[9]  Philippe Amouyel,et al.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. , 2004, Lancet.

[10]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[11]  Leonidas Stefanis,et al.  Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. , 2004, Science.

[12]  David Park,et al.  Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy , 2009, PloS one.

[13]  A. Schapira,et al.  A Novel Alpha-Synuclein Missense Mutation in Parkinson's Disease , 2012 .

[14]  John Hardy,et al.  The spread of neurodegenerative disease. , 2012, The New England journal of medicine.

[15]  Bernard Schneider,et al.  α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer* , 2012, The Journal of Biological Chemistry.

[16]  J. Hardy,et al.  Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration. , 2005, Biochemical Society transactions.

[17]  Christopher M. Dobson,et al.  Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein , 2012, Cell.

[18]  Ad Bax,et al.  Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.

[19]  Thomas Gurry,et al.  The dynamic structure of α-synuclein multimers. , 2013, Journal of the American Chemical Society.

[20]  Ronald Melki,et al.  G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome , 2013, Annals of neurology.

[21]  Peter T. Lansbury,et al.  Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.

[22]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[23]  N. Heintz,et al.  Autophagy and Its Possible Roles in Nervous System Diseases, Damage and Repair , 2005, Autophagy.

[24]  J. Hardy,et al.  Presenilin mutations line up along transmembrane alpha-helices. , 2001, Neuroscience letters.

[25]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[26]  Wei Wang,et al.  A soluble α-synuclein construct forms a dynamic tetramer , 2011, Proceedings of the National Academy of Sciences.

[27]  Janel O. Johnson,et al.  Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α‐synuclein triplication (Iowa kindred) , 2011, Movement disorders : official journal of the Movement Disorder Society.

[28]  Adam J. Trexler,et al.  N‐terminal acetylation is critical for forming α‐helical oligomer of α‐synuclein , 2012, Protein science : a publication of the Protein Society.

[29]  E. Walter,et al.  Coordination features and affinity of the Cu²+ site in the α-synuclein protein of Parkinson's disease. , 2011, Biochemistry.

[30]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[31]  A. Jonas,et al.  Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.

[32]  T. Takasu,et al.  Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies. , 1999, Acta neuropathologica.

[33]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[34]  E. Walter,et al.  Coordination of copper to the membrane-bound form of α-synuclein. , 2013, Biochemistry.

[35]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[36]  J. Hardy,et al.  Framing beta-amyloid. , 1992, Nature genetics.

[37]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[38]  P. Lansbury,et al.  The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. , 2007, Biochemistry.

[39]  F. Marken,et al.  Contribution of individual histidines to prion protein copper binding. , 2011, Biochemistry.

[40]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[41]  Patrick A. Lewis,et al.  Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.

[42]  M. Farrer,et al.  Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[43]  Ying Sun,et al.  Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies , 2011, Cell.

[44]  D. Selkoe,et al.  In Vivo Cross-linking Reveals Principally Oligomeric Forms of α-Synuclein and β-Synuclein in Neurons and Non-neural Cells* , 2013, The Journal of Biological Chemistry.

[45]  J. Hardy,et al.  Milestones in PD genetics , 2011, Movement disorders : official journal of the Movement Disorder Society.

[46]  J. Hardy,et al.  Presenilin mutations line up along transmembrane α-helices , 2001, Neuroscience Letters.

[47]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[48]  A. Alexandrescu,et al.  NMR determination of pKa values in α‐synuclein , 2011, Protein science : a publication of the Protein Society.

[49]  J. Hardy,et al.  α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy? , 2013, Acta Neuropathologica.

[50]  R. Nussbaum,et al.  Human micelle-bound alpha-synuclein , 2005 .